Resources

CAN-SPAM/E-Sign Act

Acted as the go-to advisor for a pharmaceutical company for advice on CAN-SPAM and E-Sign Act.

Firm Highlights

RxDC Reporting in Light of June 1, 2024 Deadline and Recent PBM Litigation

Under the Consolidated Appropriations Act of 2021 (“CAA”), employer-sponsored group health plans, including medical-only plans, must submit information about their prescription drugs and health care spending. [1] This submission is often referred to as...

News

Verrill Attorney Katherine E. Galloway Elected as Partner in the firm’s Private Clients & Fiduciary Services Group

Event

Exploring the Intersection: Generative AI and Employment Regulations*

The workplace is dynamic and understanding the intersection of generative AI and employment regulations is essential for both businesses and employees. Join Tawny Alvarez in this webinar where she will discuss the complex landscape...

News

Verrill Welcomes Attorney Bianca Burns to the Firm’s Litigation & Trial Group

Event

NAELA 2024 Conference

Verrill's Ruth Mattson and Katherine Galloway will presenting Irrevocable Life Insurance Trust from Start to Finish at the NAELA 2024 Conference on May 3, 2024, at 4:00pm in Boston, MA. Irrevocable Life Insurance Trusts...

Publication/Podcast

Constitutional Challenge to the CTA

Recent Development On March 1, 2024, a federal court in Alabama ruled that the Corporate Transparency Act violates the U.S. Constitution and is unenforceable on its face. The decision ( NSBU v. Yellen...

Blog

Health and Welfare Benefit Plan Fiduciary Governance in the Wake of the Johnson & Johnson Lawsuit

For the past few years, we have encouraged plan sponsors to focus on matters of fiduciary governance for their health and welfare benefit plans ( see our 2021 blog post ). Yet many plan...

Publication/Podcast

Don’t Wait – CMS Expects Hospitals to Take Action on Informed Consent for Certain Exams and Procedures

Hospitals should not delay in reviewing and revising their surgical informed consent forms and policies. On April 1, 2024, the Centers for Medicare & Medicaid Services (“CMS”) issued new guidance regarding informed consent for...

Matter

Verrill Attorneys Secure Landmark Victory in Anti-SLAPP Defense Against Business Competitors

Verrill attorneys were victorious in defending against a special motion to dismiss filed by business competitors in a case with claims for unfair and deceptive business practices and abuse of process. Bristol Asphalt Co...

Matter

Successful Representation of Insurer before U.S. District Court for the District of Maine

Verrill successfully represented an insurer before the U.S. District Court for the District of Maine in an insurance coverage matter alleging that the insurer improperly denied a defense and indemnification to a landlord under...

Contact Verrill at (855) 307 0700